A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis (NCT06979453)
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis
Who can join: Review the eligibility criteria below.
Location: Local Institution - 0261 — Birmingham, Alabama
Age range: 12 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (132 Sites)
Showing the first 25 of 132 sites.
- Local Institution - 0261 — Birmingham, Alabama
- Local Institution - 0041 — Birmingham, Alabama
- Local Institution - 0053 — Phoenix, Arizona
- Local Institution - 0025 — Fountain Valley, California
- Center For Dermatology Clinical Research, Inc. — Fremont, California
- Dermatology Research Associates — Los Angeles, California
- Northridge Clinical Trials — Northridge, California
- Local Institution - 0077 — Sacramento, California
- Golden State Dermatology - Walnut Creek - Ygnacio Valley Road — Walnut Creek, California
- Paradigm Clinical Research, LLC — Wheat Ridge, Colorado
- Local Institution - 0021 — Clearwater, Florida
- Life Clinical Trials — Margate, Florida
- Skin Research of South Florida — Miami, Florida
- Wellness Clinical Research — Miami Lakes, Florida
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research — Tampa, Florida
- USF Health — Tampa, Florida
- Dermatology Affiliates Research Institute — Atlanta, Georgia
- Advanced Medical Research, PC. — Sandy Springs, Georgia
- Local Institution - 0271 — Ammon, Idaho
- Dawes Fretzin Clinical Research Group, LLC — Indianapolis, Indiana
- Kentucky Advanced Medical Research LLC — Murray, Kentucky
- Local Institution - 0202 — Metairie, Louisiana
- Dermatology and Skin Cancer Specialists, LLC — Rockville, Maryland
- Kuchnir Dermatology & Dermatologic Surgery — Milford, Massachusetts
- Local Institution - 0095 — Detroit, Michigan
📞 Contact the Study Coordinator
Phone: (855) 907-3286
Email: Clinical.Trials@bms.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Plaque Psoriasis
- A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis — Phoenix, Arizona
- Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis — Phoenix, Arizona
- A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Birmingham, Alabama
- Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects — Rogers, Arkansas
- Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis — Birmingham, Alabama
- A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) — Phoenix, Arizona
Explore by condition: All Plaque Psoriasis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.